0001209191-20-030479.txt : 20200519
0001209191-20-030479.hdr.sgml : 20200519
20200519162823
ACCESSION NUMBER: 0001209191-20-030479
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200515
FILED AS OF DATE: 20200519
DATE AS OF CHANGE: 20200519
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Parini Michael
CENTRAL INDEX KEY: 0001661567
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 20894000
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS, INC.
STREET 2: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-05-15
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001661567
Parini Michael
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, Chief Adm, Leg & BD Off
Common Stock
2020-05-15
4
S
0
1
273.91
D
26905
D
Common Stock
2020-05-15
4
S
0
2
275.54
D
26903
D
Common Stock
2020-05-15
4
S
0
2
276.46
D
26901
D
Common Stock
2020-05-15
4
S
0
1
278.69
D
26900
D
Common Stock
2020-05-15
4
S
0
11
280.34
D
26889
D
Common Stock
2020-05-15
4
S
0
4
282.02
D
26885
D
Common Stock
2020-05-15
4
S
0
4
283.03
D
26881
D
Common Stock
2020-05-15
4
S
0
3
284.03
D
26878
D
Common Stock
2020-05-15
4
S
0
4
285.19
D
26874
D
Common Stock
2020-05-15
4
S
0
9
286.27
D
26865
D
Common Stock
2020-05-15
4
S
0
18
287.50
D
26847
D
Common Stock
2020-05-15
4
S
0
9
288.23
D
26838
D
Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $275.54 (range $275.25 to $275.83).
Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $276.46 (range $276.44 to $276.49).
Open market sales reported on this line occurred at a weighted average price of $280.34 (range $279.74 to $280.73).
Open market sales reported on this line occurred at a weighted average price of $282.02 (range $281.42 to $282.38).
Open market sales reported on this line occurred at a weighted average price of $283.03 (range $282.45 to $283.31).
Open market sales reported on this line occurred at a weighted average price of $284.03 (range $283.56 to $284.37).
Open market sales reported on this line occurred at a weighted average price of $285.19 (range $284.70 to $285.63).
Open market sales reported on this line occurred at a weighted average price of $286.27 (range $285.70 to $286.68).
Open market sales reported on this line occurred at a weighted average price of $287.50 (range $286.96 to $287.88).
Open market sales reported on this line occurred at a weighted average price of $288.23 (range $287.96 to $288.47).
/s/ Sabrina Yohai, Attorney-in-Fact
2020-05-19